Literature DB >> 21161291

Acute lung injury and alveolar epithelial function.

Tokujiro Uchida1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21161291     DOI： 10.1007/s00540-010-1063-6

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  8 in total

1.  Receptor for advanced glycation end-products is a marker of type I lung alveolar cells.

Authors:  Madoka Shirasawa; Naoyuki Fujiwara; Susumu Hirabayashi; Hideki Ohno; Junko Iida; Koshi Makita; Yutaka Hata
Journal:  Genes Cells       Date:  2004-02       Impact factor: 1.891

Review 2.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

3.  Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.

Authors:  J Brett; A M Schmidt; S D Yan; Y S Zou; E Weidman; D Pinsky; R Nowygrod; M Neeper; C Przysiecki; A Shaw
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

4.  Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

5.  Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.

Authors:  Jason D Christie; Chirag V Shah; Steven M Kawut; Nilam Mangalmurti; David J Lederer; Joshua R Sonett; Vivek N Ahya; Scott M Palmer; Keith Wille; Vibha Lama; Pali D Shah; Ashish Shah; Ann Weinacker; Clifford S Deutschman; Benjamin A Kohl; Ejigayehu Demissie; Scarlett Bellamy; Lorraine B Ware
Journal:  Am J Respir Crit Care Med       Date:  2009-08-06       Impact factor: 21.405

6.  Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury.

Authors:  Tokujiro Uchida; Madoka Shirasawa; Lorraine B Ware; Katsuo Kojima; Yutaka Hata; Koshi Makita; Gabe Mednick; Zachary A Matthay; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

7.  Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury.

Authors:  C S Calfee; L B Ware; M D Eisner; P E Parsons; B T Thompson; N Wickersham; M A Matthay
Journal:  Thorax       Date:  2008-06-19       Impact factor: 9.139

8.  Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs.

Authors:  Raphael Briot; James A Frank; Tokujiro Uchida; Jae W Lee; Carolyn S Calfee; Michael A Matthay
Journal:  Chest       Date:  2008-11-18       Impact factor: 9.410
  8 in total
  1 in total

1.  Propofol attenuates lipopolysaccharide-induced monocyte chemoattractant protein-1 production through p38 MAPK and SAPK/JNK in alveolar epithelial cells.

Authors:  Liguo Wei; Hiroko Matsumoto; Hidenori Yamaguchi
Journal:  J Anesth       Date:  2012-12-21       Impact factor: 2.078
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.